Specialized Neurological Care for the Masses

On July 22, 2015, Lakshmi Narayanan, Vice Chairman, Cognizant, and Director, Cognizant Foundation, formally presented a Critical Care Ambulance, Bio-version haemodialysis machine and Flash Autoclave Sterilizer to the Institute of Neurosciences Kolkata (I-NK) , in the presence of Dr R. P. Sengupta, Chairman and Managing Director, I-NK, Dr Hrishikesh Kumar, Vice Chairman and Head of Neurology Department, IN-K.

Set up in 2009 by eminent neurosurgeon Dr R. P. Sengupta, I-NK is a 150-bed, not-for-profit hospital that treats adults and children for neurological diseases, and offers clinical care in Neuromedicine, Neurosurgery, Neuropsychiatry, Neuroradiology including Interventional Neurology and Neurorehabilitation. The hospital also has state-of-art Department of Pathology and special clinics to treat conditions such as stroke, epilepsy, movement disorders and Parkinson’s disease.

The mid-size critical care ambulance funded by Cognizant Foundation is fitted with critical care equipment enable I-NK to safely transport an additional 50 critically ill neurological patients to the hospital every month.

The flash autoclave sterilizer will enable I-NK to improve patient safety and optimize the activities of its operation theatres by quickly sterilizing a wide range of critical instruments during emergency surgeries.

The advanced haemodialysis machine will help I-NK provide life-saving Haemodialysis to critical neurology patients who are at a high risk of developing acute renal failure. More importantly, it will help I-NK perform Plasmapheresis to treat patients suffering from life-threatening neurological diseases like Guillain–Barré syndrome in which the body’s immune system attacks the peripheral nervous system and at a much lesser cost.

“This equipment will help reduce the cost of treatment and improve the quality of care for critical neurological disorders and acute renal failure,” explained Dr R. P. Sengupta. “It will be a boon for financially weaker patients suffering from Guillain–Barré syndrome because injection-based treatment can cost up to Rs 4,00,000. Instead, by conducting Plasmapheresis through this dialysis machine, I-NK can bring down the treatment cost to Rs 75,000.